Who we are

Imagine within just weeks losing every bit of hair... all over. It's unpredictable and it happens. Alopecia areata is an autoimmune skin disease that can have a devastating affect on self-image, especially women's. Bald Girls Do Lunch is the only nonprofit created specifically to help women cope, gain confidence and feel a sense of community. Learn more...

Donate Now

BGDL Facebook Page

  • Upcoming Events

All of our invitations are in PDF format, which requires Adobe Reader. If you do not have Adobe Reader, you can download it here.



Posts


Scarsdale, NY event September 18th

August 26th, 2016 by Chassin

REGISTER with password PARTY7

Read More

Alopecia Areata Research Update from Mount Sinai

August 9th, 2016 by Chassin

Guttamn Staff
Dept of Dermatology Researchers, Icahn School of Medicine, Mount Sinai Health System

Here at Mount Sinai School of Medicine, it is an exciting time for treatment in alopecia areata. Currently we have three trials going on: an injectable, a topical and an oral. Read More

Read More

How to help a friend with alopecia areata find her true beauty

August 8th, 2016 by Chassin

alopecia areata friendship

Heidi showed us the power of her friendship in helping a close friend to live well with alopecia areata. In this follow-up we find out how Heidi does it. In fact, she told us how alopecia areata resonates with her own life, even though she herself has normal hair.

Her insights are very cool. Enjoy! Guest commentary from interview with Heidi S. of New Jersey. Read More

Read More

Friendship Makes the Difference in Alopecia Areata Support

July 12th, 2016 by Chassin

Heidi and Allison

When friendship involves alopecia, it can be an opportunity for strength and support.

That’s what Heidi from New Jersey told us when her best friend, Allison, opened up about having alopecia areata, not something she did often. Read More

Read More

Understanding Autoimmune Diseases: Is Alopecia Areata Hereditary?

June 13th, 2016 by Chassin

Is Alopecia Areata Hereditary?

As we all struggle to understand and cope with autoimmune diseases, it’s important to know what it means for your family as well.

Read English Version | Read Hebrew version גירסא אנגלית

A Lesson About Alopecia Areata in Hebrew

June 13th, 2016 by Chassin

Is Alopecia Areata Hereditary?

מחלות אוטואימוניות: האם  מחלת האלופישה אראטה היא תורשתית?

Thea Chassin, Founder and President

יוסדת הארגון  Bald Girls Do Lunch

English Version

Read the rest of this entry »

Alopecia Support in Boston

June 6th, 2016 by Chassin

Alopecia Support in Boston

 

June 13, 2016: 6 pm

Boston Renaissance Waterfront Hotel | 606 Congress St, Boston, MA

  • • Registration required.
  • • Includes one raffle for a wig from Fortune Wigs.
  • • Early bird discount: offer code BOSTON for $5 off until June 7th
  • • Questions? info@BaldGirlsDoLunch.org or 800.578.5332

Click. I want to be there!

Come to talk and share.

Our useful tips help you today.

 

Feeling Lost?

Enjoy our fun approach to self-confidence.

 

We love options. Come as you are.

All looks encouraged.

 

 

 

Clinical Trials Got Your Interest?

April 23rd, 2016 by Chassin

Dr. Emma Gutman

Mount Sinai ( New York ) has options for alopecia areata patients

Mount SinaiIs there a cure for alopecia areata? No, there is no cure, but researchers are doing clinical trials in search of safe and effective alopecia treatments. Dr. Emma Guttman, in New York is conducting several studies including a pilot study with Tralokinumab for moderate to severe alopecia areata.

Follow along with our interview so you can talk to your friends and family about new studies for alopecia treatment… Read More

Clinical Trials Underway at Mount Sinai Department of Dermatology

March 18th, 2016 by Chassin

Icahn School of Medicine at Mount Sinai (New York)

Alopecia Areata research is of great interest to people with this autoimmune skin disorder. This Bald Girls Do Lunch blog informs you with patient-friendly posts on alopecia areata news, clinical trials and popular posts like our features on Tofacitinib and Ruxolitinib. In 2016…Read More

Read More